Sökresultat - Karen Yee

Förfina resultatet
  1. 1
    Characterization of Enterovirus Activity, Including That of Enterovirus D68, in Pediatric Patients in Alberta, Canada, in 2014

    Characterization of Enterovirus Activity, Including That of Enterovirus D68, in Pediatric Patients in Alberta, Canada, in 2014 av Steven J. Drews, Kimberley Simmonds, Hussain R. Usman, Karen Yee, Sumana Fathima, Graham Tipples, Raymond Tellier, Kanti Pabbaraju, Sallene Wong, James Talbot

    Publicerad 2015
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  2. 2
    Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada

    Existing comorbidities in people with osteoarthritis: a retrospective analysis of a population-based cohort in Alberta, Canada av Deborah A. Marshall, Xiaoxiao Liu, Cheryl Barnabé, Karen Yee, Peter Faris, Claire Barber, Dianne Mosher, Thomas Noseworthy, Jason Werle, Lisa M. Lix

    Publicerad 2019
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML

    Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML av Zhihong Zeng, Dos D. Sarbassov, Ismael Samudio, Karen Yee, Mark F. Munsell, C. Ellen Jackson, Francis J. Giles, David M. Sabatini, Michael Andreeff, Marina Konopleva

    Publicerad 2006
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    Later circadian timing of food intake is associated with increased body fat

    Later circadian timing of food intake is associated with increased body fat av Andrew W. McHill, Andrew J. K. Phillips, Charles A. Czeisler, Leigh Keating, Karen Yee, Laura K. Barger, Marta Garaulet, Frank A. J. L. Scheer, Elizabeth B. Klerman

    Publicerad 2017
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms

    Treatment outcomes following leukemic transformation in Philadelphia-negative myeloproliferative neoplasms av Theodore A. Kennedy, Eshetu G. Atenafu, Hans A. Messner, Kenneth J. Craddock, Joseph Brandwein, Jeffrey H. Lipton, Mark D. Minden, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Vikas Gupta

    Publicerad 2013
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML)

    Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (m <i>IDH1</i> ) acute myeloid leukemia (AML) av Jorge E. Cortés, Brian A. Jonas, Gary J. Schiller, Alice S. Mims, Gail J. Roboz, Andrew H. Wei, Pau Montesinos, P. Brent Ferrell, Karen Yee, Pierre Fenaux, Anthony P. Schwarer, Justin M. Watts

    Publicerad 2024
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  7. 7
    Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen

    Treatment of adults with BCR‐ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen av John M. Storring, Mark D. Minden, Susan Kao, Vikas Gupta, Andre C. Schuh, Aaron D. Schimmer, Karen Yee, Suzanne Kamel‐Reid, Hong Chang, Jeffrey H. Lipton, Hans A. Messner, Wei Xu, Joseph Brandwein

    Publicerad 2009
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy

    Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: 10-Color flow cytometry diagnosis and HyperCVAD therapy av Uday Deotare, Karen Yee, Lisa W. Le, Anna Porwit, Anne Tierens, Rumina Musani, David Barth, Emina Torlakovic, Aaron D. Schimmer, Andre C. Schuh, Matthew D. Seftel, Mark D. Minden, Vikas Gupta, Elizabeth Hyjek

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Effects of High vs Low Glycemic Index of Dietary Carbohydrate on Cardiovascular Disease Risk Factors and Insulin Sensitivity

    Effects of High vs Low Glycemic Index of Dietary Carbohydrate on Cardiovascular Disease Risk Factors and Insulin Sensitivity av Frank M. Sacks, Vincent J. Carey, Cheryl A.M. Anderson, Edgar R. Miller, Trisha Copeland, Jeanne Charleston, Benjamin J. Harshfield, Nancy Laranjo, Phyllis McCarron, Janis Swain, Karen White, Karen Yee, Lawrence J. Appel

    Publicerad 2014
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Effect of Combined Gluten-Free, Dairy-Free Diet in Children With Steroid-Resistant Nephrotic Syndrome: An Open Pilot Trial

    Effect of Combined Gluten-Free, Dairy-Free Diet in Children With Steroid-Resistant Nephrotic Syndrome: An Open Pilot Trial av Juliette Léon, María José Pérez‐Sáez, Audrey Uffing, Naoka Murakami, Andréia Watanabe, Pamela Cureton, Victoria Kenyon, Leigh Keating, Karen Yee, Carla Aline Fernandes Satiro, Bryant Yu, Joseph V. Bonventre, Alessio Fasano, Leonardo V. Riella

    Publicerad 2018
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations

    Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations av Oscar Calvillo‐Argüelles, Alice Carvalhal Schöffel, José‐Mario Capo‐Chichi, Husam Abdel‐Qadir, Andre C. Schuh, Montserrat Carrillo-Estrada, Shiying Liu, Vikas Gupta, Aaron D. Schimmer, Karen Yee, Liran I. Shlush, Pradeep Natarajan, Paaladinesh Thavendiranathan

    Publicerad 2022
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia

    A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia av Gregory A. Reed, Gary J. Schiller, Suman Kambhampati, Martin S. Tallman, Dan Douer, Mark D. Minden, Karen Yee, Vikas Gupta, Joseph Brandwein, Yulia Jitkova, Marcela Gronda, Rose Hurren, Aisha Shamas‐Din, Andre C. Schuh, Aaron D. Schimmer

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial

    Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phas... av Jorge E. Cortés, Gail J. Roboz, Maria R. Baer, Brian A. Jonas, Gary J. Schiller, Karen Yee, P. Brent Ferrell, Jay Yang, Eunice S. Wang, William Blum, Alice S. Mims, Hua Tian, Aaron Sheppard, Stéphane de Botton, Pau Montesinos, Antonio Curti, Justin M. Watts

    Publicerad 2025
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  14. 14
    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies av Aaron D. Schimmer, Susan O’Brien, Hagop M. Kantarjian, Joseph Brandwein, Bruce D. Cheson, Mark D. Minden, Karen Yee, Farhad Ravandi, Francis J. Giles, Andre C. Schuh, Vikas Gupta, Michael Andreeff, Charles Koller, Hong Chang, Suzanne Kamel‐Reid, Mark S. Berger, Jean Viallet, Gautam Borthakur

    Publicerad 2008
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  15. 15
    A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia

    A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia av Ramiro Garzon, Michael R. Savona, Rachid Baz, Michael Andreeff, Nashat Gabrail, Martin Gutierrez, Lynn Savoie, Morten Mau‐Sørensen, Nina Wagner‐Johnston, Karen Yee, Thaddeus J. Unger, Jean-Richard Saint-Martin, Robert Carlson, Tami Rashal, Trinayan Kashyap, Boris Klebanov, Sharon Shacham, Michael Kauffman, Richard M. Stone

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  16. 16
    Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

    Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study av Jean–Pierre J. Issa, Gail J. Roboz, David A. Rizzieri, Elias Jabbour, Wendy Stock, Casey L. O’Connell, Karen Yee, Raoul Tibes, Elizabeth A. Griffiths, Katherine Walsh, Naval Daver, Woonbok Chung, Sue Naim, Pietro Taverna, Aram Oganesian, Yong Hao, James N. Lowder, Mohammad Azab, Hagop M. Kantarjian

    Publicerad 2015
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  17. 17
    Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study

    Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study av Guillermo Garcia‐Manero, Elizabeth A. Griffiths, David P. Steensma, Gail J. Roboz, Richard A. Wells, James McCloskey, Olatoyosi Odenike, Amy E. DeZern, Karen Yee, Lambert Busque, Casey L. O’Connell, Laura C. Michaelis, Joseph Brandwein, Hagop M. Kantarjian, Aram Oganesian, Mohammad Azab, Michael R. Savona

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  18. 18
    Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study

    Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study av Rena Buckstein, Richard A. Wells, Nancy Zhu, Heather A. Leitch, Thomas J. Nevill, Karen Yee, Brian Leber, Mitchell Sabloff, Eve St. Hilaire, Rajat Kumar, Michelle Geddes, April Shamy, John M. Storring, Andrea Kew, Mohamed Elemary, Max Levitt, Martha Lenis, Alex Mamedov, Liying Zhang, K. Rockwood, Shabbir M.H. Alibhai

    Publicerad 2016
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  19. 19
    Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia

    Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia av Gail J. Roboz, Hagop M. Kantarjian, Karen Yee, Patricia Kropf, Casey L. O’Connell, Elizabeth A. Griffiths, Wendy Stock, Naval Daver, Elias Jabbour, Ellen K. Ritchie, Katherine Walsh, David A. Rizzieri, Scott D. Lunin, Tania Curio, Woonbok Chung, Yong Hao, James N. Lowder, Mohammad Azab, Jean–Pierre J. Issa

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  20. 20
    A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

    A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts av Guillermo Garcia‐Manero, Mikkael A. Sekeres, Miklós Egyed, Massimo Breccia, Carlos Graux, Jamie Cavenagh, H Salman, Árpád Illés, Pierre Fenaux, Daniel J. DeAngelo, Reinhard Stauder, Karen Yee, Nancy Zhu, Je‐Hwan Lee, David Valcárcel, Alan Macwhannell, Z Borbényi, Lucien Gazi, Suddhasatta Acharyya, Susan Ide, Mahtab Marker, Oliver G. Ottmann

    Publicerad 2017
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: